AlphaMark Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.88M | Buy |
4,659
+7
| +0.2% | +$2.82K | 0.81% | 31 |
|
|
2024
Q3 | $2.16M | Sell |
4,652
-306
| -6% | -$142K | 0.75% | 25 |
|
|
2024
Q2 | $2.32M | Sell |
4,958
-231
| -4% | -$108K | 0.81% | 22 |
|
|
2024
Q1 | $2.17M | Sell |
5,189
-461
| -8% | -$193K | 0.76% | 23 |
|
|
2023
Q4 | $2.3M | Sell |
5,650
-130
| -2% | -$52.9K | 0.87% | 21 |
|
|
2023
Q3 | $2.01M | Sell |
5,780
-528
| -8% | -$184K | 0.86% | 20 |
|
|
2023
Q2 | $2.22M | Sell |
6,308
-1,600
| -20% | -$563K | 1.02% | 22 |
|
|
2023
Q1 | $2.49M | Sell |
7,908
-119
| -1% | -$37.5K | 1.12% | 20 |
|
|
2022
Q4 | $2.32M | Sell |
8,027
-291
| -3% | -$84K | 1.16% | 21 |
|
|
2022
Q3 | $2.41M | Buy |
8,318
+98
| +1% | +$28.4K | 1.19% | 21 |
|
|
2022
Q2 | $2.32M | Sell |
8,220
-17
| -0.2% | -$4.79K | 1.07% | 23 |
|
|
2022
Q1 | $2.15M | Buy |
8,237
+8,159
| +10,460% | +$2.13M | 0.8% | 32 |
|
|
2021
Q4 | $17K | Buy |
78
+50
| +179% | +$10.9K | 0.01% | 350 |
|
|
2021
Q3 | $5K | Hold |
28
| – | – | ﹤0.01% | 468 |
|
|
2021
Q2 | $6K | Hold |
28
| – | – | ﹤0.01% | 447 |
|
|
2021
Q1 | $6K | Buy |
28
+20
| +250% | +$4.29K | ﹤0.01% | 429 |
|
|
2020
Q4 | $2K | Hold |
8
| – | – | ﹤0.01% | 483 |
|
|
2020
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 499 |
|
|
2020
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 498 |
|
|
2020
Q1 | $2K | Sell |
8
-47
| -85% | -$11.8K | ﹤0.01% | 477 |
|
|
2019
Q4 | $12K | Buy |
55
+15
| +38% | +$3.27K | 0.01% | 317 |
|
|
2019
Q3 | $7K | Sell |
40
-2
| -5% | -$350 | ﹤0.01% | 370 |
|
|
2019
Q2 | $8K | Hold |
42
| – | – | ﹤0.01% | 363 |
|
|
2019
Q1 | $8K | Hold |
42
| – | – | ﹤0.01% | 354 |
|
|
2018
Q4 | $7K | Buy |
42
+32
| +320% | +$5.33K | ﹤0.01% | 354 |
|
|
2018
Q3 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 476 |
|